Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience

Journal of the International Association of Physicians in AIDS Care

Volumn 5, Issue 3, 2006, Pages 103-108

  Hosseinipour, Mina C ^a   Neuhann, Florian H ^b,c   Kanyama, Cecelia C ^a   Namarika, Dan C ^d   Weigel, Ralf ^b   Miller, William ^e   Phiri, Sam J P ^b  

^a UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^b LIGHTHOUSE TRUST   (Malawi)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KAMUZU CENTRAL HOSPITAL   (Malawi)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Africa; AIDS; antiretroviral therapy; HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; ECONOMICS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; MALE; MIDDLE AGED; MORTALITY; OUTPATIENT DEPARTMENT; PATIENT; RETROSPECTIVE STUDY; STATISTICS;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALAWI; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT DROPOUTS; RETROSPECTIVE STUDIES;

EID: 34248508084     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109706288722     Document Type: Article

References (17)

1. AIDS Epidemic Update 2002. Joint United Nations Programme on HIV/AIDS Web site. Available at: http://www.unaids.org/worldaidsday/2002/press/Epiupdate. html Malawi Fact Sheet.
2. UNAIDS HIV Drug Access Initiative. Providing Wider Access to HIV-Related Drugs in Developing Countries. Pilot Phase. Report of the Meeting on the Evaluation of the Initiative (20-31 May 2000). Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS ; 2000.
3. Tassie JM, Szumilin E, Calmy A, Goemaere E, Medicins Sans Frontieres. Highly active antiretroviral therapy in resource-poor settings: the experience of Medecins Sans Frontieres. AIDS. 2003 ; 5: 17: 1995-1997. (Pubitemid 37074829)
4. Laurent C, Kouanfack C, Koulla-Shiro S, et al. Effectiveness and safety of a generic fixed dose combination of nevirapine, stavudine, and lamivudine in HIV-1 infected adults in Cameroon: open-label multicentre trial. Lancet. 2004 ; 364: 29-34. (Pubitemid 38968622)
5. World Development Indicators Database: Malawi Data Profile [database online]. Washington, DC: The World Bank ; 2003. Available at: http://devdata.worldbank.org.
6. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005 ; 41: 217-224. (Pubitemid 40962502)
7. Siegfried N, Clarke M, Volminck J. Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution. BMJ. 2005 ; 331: 742-746. (Pubitemid 41414942)
8. Kushner AL, Mannion SJ, Muyco AP. Secondary crisis in African health care [letter]. Lancet. 2004 ; 363: 1478-1478.
9. Van Leth F, Phanuphak P, Ruxrungtham K, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomized open-label trial, the 2NN study. Lancet. 2004 ; 363: 1253-1263. (Pubitemid 38496486)
10. Montaner JS, Reiss P, Cooper D, et al. A randomized double-blind trial comparing combinations of nevirapine didanosine and zidovudine for HIV-infected patients: the INCAS trial. JAMA. 1998 ; 279: 930-937. (Pubitemid 28136082)
11. Stavudine [prescribing information]. New York, NY: Bristol-Myers Squibb Pharmaceuticals.
12. Hosseinipour M, Neuhann F, Kanyama C, Namarika D, Phiri S. Mortality is the leading cause of loss to follow-up among antiretroviral patients in Malawi. 11th Conference on Retroviruses and Opportunistic Infections ; February 8-11, 2004 ; San Francisco, CA. Abstract #594.
13. Lawn SD, Myer L, Wood R. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? [letter]. Clin Infect Dis. 2005 ; 41: 1683-1683.
14. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after 2 years of providing antiretroviral treatment in South Africa. AIDS. 2004 ; 18: 887-895. (Pubitemid 38553709)
15. Malawi Ministry of Health. Treatment of AIDS: The 2-Year Plan to Scale Up Antiretroviral Therapy in Malawi. Lilongwe, Malawi: Malawi Ministry of Health ; 2004.
16. Harries AD, Libamba E, Schouten E, Mwansambo A, Salaniponi F, Mpazanje R. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ. 2004 ; 329: 1163-1166. (Pubitemid 39524779)
17. Colebunders R, Kamya M, Semitala F, Castelnuovo B, Katabira E, McAdam K. Free antiretroviral must not be restricted only to treatment-naive patients. Plos Med. 2005 ; 2: e276 - e276.